Přejít k hlavnímu obsahu
Header image

Impact Factor Journals

GACHECHILADZE, M., I. ÜBERALL, D. SKANDEROVÁ, J. MATCHAVARIANI, M. IBRAHIM, I. SHANI, P. SMICKOVA, V. KOLEK, L. CIERNA, R. STAHEL, M. JOERGER, A. SOLTERMANN, J. ŠKARDA
LC3A positive "stone like structures" are differentially associated with survival outcomes and CD68 macrophage infiltration in patients with lung adenocarcinoma and squamous cell carcinoma. Lung Cancer. 2021, 156, 129-135, ISSN: 0169-5002, PMID: 33962766,
PORUBSKÝ, M., S. GURSKÁ, J. STANKOVÁ, M. HAJDÚCH, P. DŽUBÁK, J. HLAVÁČ
AminoBODIPY Conjugates for Targeted Drug Delivery Systems and Real-Time Monitoring of Drug Release. Molecular Pharmaceutics. 2021, 18(6), 2385-2396, ISSN: 1543-8384, PMID: 33961440,
KUGLER, M., J. NEKVINDA, J. HOLUB, S. EL ANWAR, V. DAS, V. SICHA, K. POSPISILOVA, M. FABRY, V. KRAL, J. BRYNDA, V. KASICKA, M. HAJDÚCH, P. ŘEZÁČOVÁ, B. GRUNER
Inhibitors of CA IX Enzyme Based on Polyhedral Boron Compounds. Chembiochem : a European Journal of Chemical Biology. 2021, 22(18), 2741-2761, ISSN: 1439-4227, PMID: 33939874,
REISSIG, F., D. BAUER, K. ZARSCHSLER, Z. NOVÝ, K. DVOŘÁKOVÁ BENDOVÁ, M. ĹUDIK, K. KOPKA, H. PIETZSCH, M. PETŘÍK, C. MAMAT
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA-A Proof of Concept Study. Cancers. 2021, 13(8), 1974, ISSN: 2072-6694, PMID: 33923965,  PDF.
BACHOŘÍK, J., M. URBAN
Biocatalysis in the Chemistry of Lupane Triterpenoids. Molecules. 2021, 26(8), 2271, ISSN: 1420-3049, PMID: 33919839,  PDF.
JAWOREK, H., V. KOUDELÁKOVÁ, I. OBORNA, B. ZBORILOVA, J. BREZINOVA, D. RUZICKOVA, J. VRBKOVÁ, P. KOUŘILOVÁ, M. HAJDÚCH
Prevalence and genotype distribution of human papillomavirus in Czech non-vaccinated heterosexual couples. Virology Journal. 2021, 18(1), 80, ISSN: 1743-422X, PMID: 33858457,
STEFEKOVA, A., P. CAPKOVA, Z. CAPKOVA, V. CURTISOVA, J. SROVNAL, E. MRACKA, E. KLASKOVA, M. PROCHAZKA
MLPA analysis of 32 foetuses with a congenital heart defect and 1 foetus with renal defects - pilot study. The significant frequency rate of presented pathological CNV. Biomedical Papers - Olomouc. 2021, 166(2), 187-194, ISSN: 1213-8118, PMID: 33824538,
NOVÝ, Z., J. JANOUSEK, P. BARTA, M. PETŘÍK, M. HAJDÚCH, F. TREJTNAR
Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging. Journal of Labelled Compounds & Radiopharmaceuticals. 2021, 64(7), 262-270, ISSN: 0362-4803, PMID: 33818828,
DOSTAL, Z., M. SEBERA, J. SROVNAL, K. ŠTAFFOVÁ, M. MODRIANSKÝ
Dual Effect of Taxifolin on ZEB2 Cancer Signaling in HepG2 Cells. Molecules. 2021, 2021(26), 1476, ISSN: 1420-3049, PMID: 33803107,  PDF.
KALITA, O., Z. ŠPORIKOVÁ, M. HAJDÚCH, M. HOUDOVÁ MEGOVÁ, R. SLAVKOVSKÝ, L. HRABALEK, M. HALAJ, Y. KLEMENTOVÁ, M. DOLEZAL, J. DRÁBEK, L. TUCKOVA, J. EHRMANN, J. VRBKOVÁ, R. TROJANEC, M. VAVERKA
The Influence of Gene Aberrations on Survival in Resected IDH Wildtype Glioblastoma Patients: A Single-Institution Study. Current Oncology. 2021, 28(2), 1280-1293, ISSN: 1198-0052, PMID: 33801093,  PDF.